Author Archives: Ofelia Rodriguez, MD and Sandra Grosworsel Schefler

Weighing in on Criticism of Foreign Trials

A recent report by Daniel Levinson, inspector general at FDA, found that “Central and South America had the highest number of subjects per site and accounted for 26% of all subjects enrolled at foreign trial sites.” We’re not at all surprised by those statistics—we’ve witnessed firsthand the impressive growth of clinical research in the region.
Posted in CRO/Sponsor | Tagged , , , , , , , , , | Leave a comment